7773297 |
Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3
Tavormina, PL,
Shiang, R,
Thompson, LM,
Zhu, YZ,
Wilkin, DJ,
Lachman, RS,
Wilcox, WR,
Rimoin, DL,
Cohn, DH,
Wasmuth, JJ
|
Nat Genet |
1995 |
8845844 |
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
Rousseau, F,
El Ghouzzi, V,
Delezoide, AL,
Legeai-Mallet, L,
Le Merrer, M,
Munnich, A,
Bonaventure, J
|
Hum Mol Genet |
1996 |
8589699 |
Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I
Tavormina, PL,
Rimoin, DL,
Cohn, DH,
Zhu, YZ,
Shiang, R,
Wasmuth, JJ
|
Hum Mol Genet |
1995 |
11529856 |
Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)
Intini, D,
Baldini, L,
Fabris, S,
Lombardi, L,
Ciceri, G,
Maiolo, AT,
Neri, A
|
Br J Haematol |
2001 |
12368157 |
Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis
Soverini, S,
Terragna, C,
Testoni, N,
Ruggeri, D,
Tosi, P,
Zamagni, E,
Cellini, C,
Cavo, M,
Baccarani, M,
Tura, S,
Martinelli, G
|
Haematologica |
2002 |
19327639 |
Identification of novel fibroblast growth factor receptor 3 gene mutations in actinic cheilitis and squamous cell carcinoma of the lip
Chou, A,
Dekker, N,
Jordan, RC
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
2009 |
10471491 |
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
Cappellen, D,
De Oliveira, C,
Ricol, D,
de Medina, S,
Bourdin, J,
Sastre-Garau, X,
Chopin, D,
Thiery, JP,
Radvanyi, F
|
Nat Genet |
1999 |